Immunosuppressant-Free Retinal Stem Cell Transplant Feasible

Share this content:
Immunosuppressant-Free Retinal Stem Cell Transplant Feasible
Immunosuppressant-Free Retinal Stem Cell Transplant Feasible

THURSDAY, Sept. 15, 2016 (HealthDay News) -- Scientists report they have successfully transplanted reprogrammed monkey stem cells into the eyes of other monkeys without the need for immunosuppressants. These results were published online Sept. 15 in Stem Cell Reports.

To assess the effectiveness of major histocompatibility complex (MHC) matching, the researchers behind the new study took retinal pigment cells from a stem cell bank that were grown from monkey induced pluripotent stem cells and transplanted them into the eyes of other monkeys. Some monkeys were given genetically matched MHCs, while others received mismatched MHCs.

Rejection occurred fairly quickly among the MHC-mismatched monkeys, the researchers found. But the transplanted cells in the MHC-matched monkeys survived without rejection for at least six months with no use of drugs to weaken the immune system. T cells did not respond to the transplanted retinal pigment cells if they were from an MHC-matched monkey.

In a second study in the same issue of the journal, the researchers repeated these experiments using human cells in the lab. The results were similar to those observed in the monkey trial.

Full Text 1
Full Text 2

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths